NORTH AMERICA CONTRACEPTIVES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

NORTH AMERICA CONTRACEPTIVES MARKET 2019-2027

Market By Education, Age Group, Drugs & Devices, End Users And Geography | Forecasts 2019-2027

Request Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The North America contraceptive market is anticipated to proliferate at a CAGR of 6.46% during the forecast period 2019-2027.

In the North American contraceptive market, the following countries have been covered:

O    The United States

O    Canada

The North America contraceptive market holds the maximum market share in this industry globally. The increasing adoption of contraceptives in this region can be largely attributed to the growing consciousness among the population about the importance of contraceptives. The rising cases of unplanned pregnancies, measures taken by the government to control the birth rate and the need to evade STIs. Individuals today have become largely health-conscious, and due to the increase in their disposable income, they are willing to spend on contraceptives and other preventive measures. Technological enhancements make contraceptives an effective birth control method. All these factors will go a long way in boosting the market. However, lack of awareness and misperceptions regarding the use of contraceptives have hindered the market growth. In addition, Contraceptives also bring the risk of side-effects such as breast cancer, blood clots, strokes, etc., which is an issue that requires serious consideration.

The North American market can be classified based on age group, education, drugs & devices and end users. Women in the US were provided with health insurance coverage by the government, to help them adopt contraceptives for birth control. However, due to policy changes made by the Trump government, access to these facilities has become arduous. A significant percentage of Canadian women are not able to avail the advantages of birth control due to the stagnancy of the market. Limited availability of products and lack of favorable governmental policies have proven to be a major barrier for the growth f this market.

The top contraceptive-manufacturing companies in this region are Bayer AG, Pregna, Apothecus Pharmaceutical Corporation, Teva Pharmaceutical Industries, Ltd., Pfizer, Inc., Reckitt Benckiser PLC, SMB Corporation, Afaxys, Inc., Mayer Laboratories, Inc., Melbea, Allergan, Inc., Ocon Medical, Ltd., Merck & Co., Inc., Church & Dwight Co., Inc., Okamoto Industries, Inc., Cooper Surgical, Inc. and Agile Therapeutics.


Related Reports

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027
Lifesciences

ASIA PACIFIC ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2019-2027

Market By Offerings, Technolog ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027
Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027

Market By Therapeutics & Diagn ..

VIEW REPORT
ASIA-PACIFIC BIOSURGERY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BIOSURGERY MARKET 2019-2027

Market By Product, Application ..

VIEW REPORT
ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027
Lifesciences

ASIA-PACIFIC BLOOD PLASMA MARKET 2019-2027

Market By Blood Type, Applicat ..

VIEW REPORT
ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2019-2027

Market By Test Types, Technolo ..

VIEW REPORT
ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CLEANROOM TECHNOLOGY MARKET 2019-2027

Market By Component, End-user ..

VIEW REPORT
ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC CONTRACEPTIVE MARKET 2019-2027

Market By Age Group, Education ..

VIEW REPORT

Table of Content

1.    CONTRACEPTIVE MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.           THREAT OF NEW ENTRANTS

2.2.2.           THREAT OF SUBSTITUTE

2.2.3.           BARGAINING POWER OF BUYERS

2.2.4.           BARGAINING POWER OF SUPPLIERS

2.2.5.           THREAT OF COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. PESTEL OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET PLAYER POSITIONING

2.7. KEY INSIGHTS

2.7.1.           ORAL CONTRACEPTIVE ARE THE MAJORLY USED CONTRACEPTIVE DRUGS

2.7.2.           CONDOMS ARE THE WIDELY USED CONTRACEPTIVES DEVICE

2.7.3.           AGE GROUP OF 15–24 YEARS ARE THE MAJOR REVENUE CONTRIBUTORS TO THE NORTH AMERICA CONTRACEPTIVE MARKET

2.8. MARKET DRIVERS

2.8.1.           GROWING COGNIZANCE FOR CONTRACEPTIVES

2.8.2.           INCREASING USAGE OF ORAL CONTRACEPTIVES TO EVADE UNPLANNED PREGNANCY

2.8.3.           SURGE IN THE INITIATIVES OF GOVERNMENT AND NGO

2.8.4.           GROWING AWARENESS ABOUT STD

2.9. MARKET RESTRAINTS

2.9.1.           SIDE EFFECTS RESTRICTING THE GROWTH OF CONTRACEPTIVES

2.9.2.           LIMITED ACCESS TO CONTRACEPTIVES

2.10.            MARKET OPPORTUNITIES

2.10.1.        RISING DISPOSABLE INCOME IN EMERGING ECONOMIES

2.10.2.        UNMET MEDICAL NEEDS IN THE EMERGING ECONOMIES

2.10.3.        TECHNOLOGICAL ADVANCEMENTS

2.11.            MARKET CHALLENGES

2.11.1.        LACK OF ACCEPTANCE OF SOCIETY

3.    CONTRACEPTIVE MARKET OUTLOOK - BY EDUCATION

3.1. LESS THAN HIGH SCHOOL

3.2. HIGH SCHOOL GRADUATE

3.3. COLLEGE GRADUATE

3.4. OTHER COLLEGE DEGREES

4.    CONTRACEPTIVE MARKET OUTLOOK - BY AGE GROUP

4.1. 15–24 YEARS

4.2. 25–34 YEARS

4.3. 35–44 YEARS

4.4. ABOVE 44 YEARS

5.    CONTRACEPTIVE MARKET OUTLOOK - BY END USER

5.1. HOUSEHOLDS

5.2. CLINICS

5.3. HOSPITALS

6.    CONTRACEPTIVE MARKET OUTLOOK - BY DRUGS AND DEVICES

6.1. CONTRACEPTIVES DRUGS

6.1.1.           ORAL CONTRACEPTIVE PILLS

6.1.2.           INJECTABLE CONTRACEPTIVES

6.1.3.           TOPICAL CONTRACEPTIVES

6.2. CONTRACEPTIVE DEVICES

6.2.1.           MALE CONDOMS

6.2.2.           FEMALE CONDOMS

6.2.3.           DIAPHRAGMS

6.2.4.           CONTRACEPTIVE SPONGES

6.2.5.           VAGINAL RINGS

6.2.6.           SUBDERMAL IMPLANTS

6.2.7.           INTRA-UTERINE DEVICES

6.2.7.1.      COPPER INTRA-UTERINE DEVICES

6.2.7.2.      HORMONAL INTRA-UTERINE DEVICES

7.    CONTRACEPTIVE MARKET - REGIONAL OUTLOOK

7.1. NORTH AMERICA

7.1.1.           COUNTRY ANALYSIS

7.1.2.      THE UNITED STATES

7.1.3.      CANADA

8.    COMPETITIVE LANDSCAPE

8.1. COMPANY PROFILES

8.1.1.           ALLERGAN INC.

8.1.2.           BAYER AG

8.1.3.           MELBEA

8.1.4.           PREGNA

8.1.5.           PFIZER, INC.

8.1.6.           CHURCH & DWIGHT CO., INC.

8.1.7.           AFAXYS, INC.

8.1.8.           APOTHECUS PHARMACEUTICAL CORPORATION

8.1.9.           COOPER SURGICAL INC

8.1.10.        OKAMOTO INDUSTRIES, INC

8.1.11.        MAYER LABORATORIES, INC.

8.1.12.        AGILE THERAPEUTICS

8.1.13.        MERCK & CO., INC.

8.1.14.        RECKITT BENCKISER PLC

8.1.15.        SMB CORPORATION

8.1.16.        TEVA PHARMACEUTICAL INDUSTRIES LTD.

8.1.17.        OCON MEDICAL LTD

9.    METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of table

TABLE 1        NORTH AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

TABLE 2        CONTRACEPTIVE   MARKET PLAYER POSITIONING OUTLOOK 2017

TABLE 3        NORTH AMERICA CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

TABLE 4        NORTH AMERICA CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

TABLE 5        NORTH AMERICA CONTRACEPTIVE MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

TABLE 7        NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 8        NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 9        NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      NORTH AMERICA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 2      PORTER’S FIVE FORCE MODEL

FIGURE 3      NORTH AMERICA CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

FIGURE 4      NORTH AMERICA CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

FIGURE 5      NORTH AMERICA CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

FIGURE 6      NORTH AMERICA CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

FIGURE 8      NORTH AMERICA CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

FIGURE 10   NORTH AMERICA CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

FIGURE 13   NORTH AMERICA CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 14   NORTH AMERICA CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

FIGURE 15   NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

FIGURE 16   NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 17   NORTH AMERICA CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

FIGURE 18   NORTH AMERICA CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

FIGURE 19   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 20   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

FIGURE 21   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

FIGURE 22   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

FIGURE 23   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

FIGURE 24   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

FIGURE 25   NORTH AMERICA CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 26   NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 27   NORTH AMERICA INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

FIGURE 28   THE UNITED STATES CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

FIGURE 29   CANADA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;